4d Molecular Therapeutics
Clinical trials sponsored by 4d Molecular Therapeutics, explained in plain language.
-
One-Shot gene therapy could slash eye injections for wet AMD
Disease control Recruiting nowThis study tests a gene therapy called 4D-150 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment is given as a single injection into the eye and aims to reduce the need for frequent anti-VEGF injections. About 215 adults aged…
Phase: PHASE1, PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Inhaled gene therapy aims to tackle cystic fibrosis from within
Disease control Recruiting nowThis early-stage trial tests a single inhaled dose of a gene therapy called 4D-710 in 30 adults with cystic fibrosis who cannot use current modulator drugs. The goal is to see if the treatment is safe and tolerable. Researchers will monitor side effects and changes in lung functi…
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
One shot to save sight? gene therapy trial aims to cut eye injections for wet AMD
Disease control Recruiting nowThis phase 3 trial tests a single injection of 4D-150 gene therapy in 480 adults with wet age-related macular degeneration (nAMD). The goal is to see if one treatment can control the disease and reduce the need for regular eye injections over two years. Participants must be 50 or…
Phase: PHASE3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC